A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance
Autor: | Bernhard Zöllner, Matthias Schröter, Rainer Laufs, Peter H. Schafer, Bärbel Knödler, Heinz Hubert Feucht |
---|---|
Rok vydání: | 2003 |
Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Hepatitis C virus Viremia medicine.disease_cause Polymerase Chain Reaction Virus law.invention Liver disease Renal Dialysis law Virology Epidemiology Prevalence medicine Humans Circoviridae Infections Polymerase chain reaction Aged Retrospective Studies Aged 80 and over Circoviridae business.industry DNA virus Middle Aged medicine.disease Infectious Diseases Immunology Female Hemodialysis business |
Zdroj: | Journal of Clinical Virology. 27:69-73 |
ISSN: | 1386-6532 |
DOI: | 10.1016/s1386-6532(02)00129-4 |
Popis: | Background: A recently discovered DNA virus (SEN) has been assumed to be responsible for posttransfusion hepatitis in humans. Phylogenetic analysis of SEN virus has revealed the existence of 8 different strains. Two of them (SEN virus strain H (SENV-H) and SENV-D) have been described as possible candidate viruses for inducing posttransfusion hepatitis. Until now, it is unclear whether patients on maintenance hemodialysis are on increased risk for acquiring SEN virus. Objectives: To investigate the prevalence of SENV-H among patients on maintenance hemodialysis and to examine whether special measures have to be taken to prevent nosocomial spreading of the virus. Study design: Serum samples derived from 78 chronically hemodialysed patients were examined for SENV-H viremia by seminested polymerase chain reaction. A panel of 226 samples from healthy blood donors served as a control group. Results: The prevalence of SENV-H was determined to be 12.8% (n=10) among patients on maintenance hemodialysis. This is nearly the same prevalence as in healthy blood donors (16.8%; n=38). None of the solely SENV-H-viremic individuals had clinical or biochemical signs of liver disease. Enhanced severity of liver disease could not be observed in patients coinfected with hepatitis C virus and SENV-H. Conclusion: We conclude that SENV-H viremia is widespread among hemodialysis patients. Since no viremic patient had clinical or biochemical signs of liver disease, in our setting the hepatitis-inducing capacity of SENV-H remains unclear. On the basis of our results, at present, we do not regard it as necessary to dialyse SENV-H-viremic patients on separate machines. |
Databáze: | OpenAIRE |
Externí odkaz: |